Access cutting-edge bronchiolitis obliterans treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orlando location
Access bronchiolitis obliterans specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bronchiolitis obliterans treatment provided free
Check if you qualify for this bronchiolitis obliterans clinical trial in Orlando, FL
No-Cost Study Care
Local to Orlando
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this Phase 3 clinical trial is to compare ARINA-1 (a nebulized immunomodulatory agent) plus Standard of Care vs Standard of Care alone. The main question it aims to answer are: * Evaluate the effectiveness of ARINA-1 in preventing bronchiolitis obliterans syndrome (BOS) progression in participants with a bilateral lung transplant * To evaluate the effectiveness of ARINA-1 on improving quality of life decline and preventing or delaying the use of augmented immunosuppression in partic
Sponsor: Renovion, Inc.
Yes, this clinical trial (NCT05654922) has an active research site in Orlando, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for bronchiolitis obliterans treatment options in Orlando, FL, this clinical trial (NCT05654922) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bronchiolitis obliterans specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all bronchiolitis obliterans clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Orlando — not just this study.
Browse Rheumatoid Arthritis Trials in Orlando →